FierceBiotech2h
Metsera links GLP-1 drug to 11% weight loss after 12 weeks, teeing up trial of monthly dosing
Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...
Ozempic ‘microdosing’ is gaining popularity — but is it effective?
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.
NJBIZ16h
GLP-1 users spend less at the supermarket, Cornell study finds
As the weight-loss drugs become more popular, consumer habits are starting to reflect changing consumption behavior, ...
Blast fat fast with our ‘Nozempic diet’ – all the benefits of weight loss jabs WITHOUT the nasty side effects
KEEN to lose weight in 2025? So are almost half of our readers. While weight-loss jabs, similar to Ozempic, boomed in ...
Campaign US23h
Currax covers Lesley Gore to tell patients cravings don’t own them
Currax Pharmaceuticals is taking a page out of Lesley Gore’s playbook to remind patients that obesity doesn’t own them. The drugmaker launched a campaign supporting its weight loss medication ...
israelnewsonline13h
Eli Lilly Zepbound causes more weight loss than Novo Nordisk Wegovy: Trial
A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, manufactured by Novo Nordisk. Reuters Eli Lilly said Wednesday that its obesity drug Zepbound ...
Daily Journal21h
Medicaid coverage of weight-loss drugs could cost Indiana up to $70 million a year
Indiana’s Medicaid program estimates the Biden administration’s proposal to expand coverage of weight-loss treatment for ...